204013-09-2Relevant academic research and scientific papers
Chemical compounds
-
, (2008/06/13)
The invention provides compounds of formula (I): as modulators of chemokine and H1 receptor activity. The compounds are especially useful in the treatment of asthma and rhinitis.
Chemical compounds
-
, (2008/06/13)
The invention concerns compounds of formula (I), and their use in therapy, particularly in the modulation of CCR3 activity.
Chemical compounds
-
, (2008/06/13)
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
